CCXI — CHEMOCENTRYX INC
As of Q2 2026, 12 SEC-registered investment managers reported holding CCXI (CHEMOCENTRYX INC) in their latest 13F filings, with a combined reported value of $121.59M across 7.13M shares. That is +141.6% by share count (+4.18M shares) versus the previous quarter, while reported value moved +305.0%. Ownership is concentrated: the five largest holders account for 95.4% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 7 opened new positions, 2 added to existing stakes, 1 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CCXI is classified in the Financials sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q3 2022 | 6.02M | $311.02M | 0.01% | Add |
| Goldman Sachs Group history | Q3 2022 | 5.62M | $290.14M | 0.07% | Add |
| Soros Fund Management history | Q3 2022 | 1.58M | $81.36M | 1.98% | New |
| Citadel Advisors history | Q2 2026 | 3.25M | $53.93M | 0.01% | New |
| PSP Investments history | Q3 2022 | 847.00K | $43.76M | 0.39% | New |
| Invesco Ltd history | Q3 2022 | 825.10K | $42.62M | 0.01% | Reduce |
| Farallon Capital Management history | Q3 2022 | 800.00K | $41.33M | 0.26% | New |
| Balyasny Asset Management history | Q3 2022 | 713.03K | $36.84M | 0.12% | New |
| Principal Global Investors history | Q3 2022 | 661.88K | $34.19M | 0.03% | Add |
| Northern Trust Corp history | Q3 2022 | 658.61K | $34.02M | 0.01% | Add |
| Charles Schwab Investment Management history | Q3 2022 | 457.77K | $23.65M | 0.01% | Add |
| D. E. Shaw & Co history | Q2 2026 | 1.30M | $22.64M | 0.01% | Hold |
| Bank of America Corp history | Q3 2022 | 360.04K | $18.60M | 0.00% | Add |
| T. Rowe Price Associates history | Q3 2022 | 320.46K | $16.56M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 908.80K | $15.86M | 0.01% | New |
| Deutsche Bank AG history | Q3 2022 | 278.00K | $14.36M | 0.01% | Add |
| BNY Mellon history | Q3 2022 | 267.63K | $13.83M | 0.00% | Add |
| Wellington Management Group history | Q3 2022 | 248.94K | $12.86M | 0.00% | Reduce |
| Moore Capital Management history | Q2 2026 | 700.00K | $12.21M | 0.19% | Reduce |
| Two Sigma Investments history | Q2 2026 | 652.50K | $11.39M | 0.01% | Hold |
New Positions (Q2 2026)
- Citadel Advisors 3.25M sh · $53.93M
- Millennium Management 908.80K sh · $15.86M
- JPMorgan Chase & Co 73.52K sh · $1.21M
- Polen Capital Management 45.59K sh · $795.55K
- Geode Capital Management 24.77K sh · $432.27K
- Citigroup Inc 12.50K sh · $218.12K
- Wells Fargo & Co 700 sh · $12.21K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|
| Citadel Advisors | 1.75M | 1.13M | 622.93K | 514.12K | 279.38K | — | 3.25M |
| D. E. Shaw & Co | 65.83K | 25.90K | 20.00K | 28.91K | 72.52K | 1.30M | 1.30M |
| Millennium Management | 641.45K | 1.23M | 1.30M | 370.69K | 983.81K | — | 908.80K |
| Moore Capital Management | — | 321.20K | 334.25K | — | — | 1.00M | 700.00K |
| Two Sigma Investments | 82.80K | 836.53K | 781.99K | 11.50K | — | 652.50K | 652.50K |
| UBS Group AG | 109.27K | 11.38K | 168.17K | 94.34K | 115.48K | 3.78K | 165.84K |
| JPMorgan Chase & Co | 47.34K | 44.53K | 118.64K | 56.06K | 211.08K | — | 73.52K |
| Polen Capital Management | — | — | — | — | — | — | 45.59K |
| Geode Capital Management | 935.42K | 932.17K | 1.00M | 1.01M | 1.15M | — | 24.77K |
| Citigroup Inc | 203.50K | 133.27K | 100.40K | 159.43K | 141.17K | — | 12.50K |
| Wells Fargo & Co | 360.57K | 77.05K | 25.09K | 4.66K | 3.50K | — | 700 |
| Morgan Stanley | 166.14K | 388.60K | 422.51K | 907.39K | 684.16K | 20 | 202 |
| Point72 Asset Management | 319.60K | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 10.49M | 10.50M | 10.63M | 10.68M | 7.80K | — | — |
| Goldman Sachs Group | 298.54K | 537.29K | 385.98K | 478.07K | 5.62M | — | — |
| Soros Fund Management | — | — | — | — | 1.58M | — | — |
| Deutsche Bank AG | 57.06K | 53.45K | 52.70K | 78.61K | 278.00K | — | — |
| CPP Investments | — | — | — | 40.50K | — | — | — |
| AQR Capital Management | — | — | — | 8.77K | 19.84K | — | — |
| Arrowstreet Capital | — | — | — | — | 106.86K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details